bioSyntagma - 2018 AZBio Fast Lane Honoree


Published: 2018-10-18 03:08:37


bioSyntagma is a precision medicine company that provides deep data on the uniqueness of each person’s cancer to transform how their cancer is treated.  

bioSyntagma serves the needs of clinicians, academic researchers, and drug developers to advance the implementation of precision medicine. 

The company has developed a device that enables researchers and drug developers to physically map cancer tissues for biological markers that predict the response to treatments and outcomes. 

Categories: Innovations
Sign in or Create an account to comment!